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Abstract. 
 
Reactive oxygen species (ROS) are thought 
to be involved in many forms of programmed cell 
death. The role of ROS in cell death caused by oxida-
tive glutamate toxicity was studied in an immortalized 
mouse hippocampal cell line (HT22). The causal rela-
tionship between ROS production and glutathione 
(GSH) levels, gene expression, caspase activity, and cy-
tosolic Ca
 
2
 
1
 
 concentration was examined. An initial 
5–10-fold increase in ROS after glutamate addition is 
temporally correlated with GSH depletion. This early 
increase is followed by an explosive burst of ROS pro-
duction to 200–400-fold above control values. The 
source of this burst is the mitochondrial electron trans-
port chain, while only 5–10% of the maximum ROS 
production is caused by GSH depletion. Macromolecu-
lar synthesis inhibitors as well as Ac-YVAD-cmk, an 
interleukin 1
 
b
 
–converting enzyme protease inhibitor, 
block the late burst of ROS production and protect 
HT22 cells from glutamate toxicity when added early in 
the death program. Inhibition of intracellular Ca
 
2
 
1
 
 cy-
cling and the influx of extracellular Ca
 
2
 
1
 
 also blocks 
maximum ROS production and protects the cells. The 
conclusion is that GSH depletion is not sufficient to 
cause the maximal mitochondrial ROS production, and 
that there is an early requirement for protease activa-
tion, changes in gene expression, and a late require-
ment for Ca
 
2
 
1
 
 mobilization.
 
T
 
he
 
 production of reactive oxygen species (ROS)
 
1
 
 is
associated with many forms of apoptosis (Suzuki
et al., 1997), as well as the cell death that occurs in
stroke, ischemia, and many neurodegenerative diseases
(Halliwell, 1992; Ames et al., 1993; Coyle and Puttfarcken,
1993; Jenner, 1994; Shigenaga et al., 1994). Glutamate tox-
icity is a major contributor to pathological cell death
within the nervous system and appears to be mediated
by ROS (Coyle and Puttfarcken, 1993). There are two
forms of glutamate toxicity: receptor-initiated excitotoxicity
(Choi, 1988) and non–receptor-mediated oxidative glutamate
toxicity (Murphy et al., 1989). Oxidative glutamate toxicity
is initiated by high concentrations of extracellular glutamate
that prevent cystine uptake into the cells, followed by the
depletion of intracellular cysteine and the loss of glutathione
(GSH). With a diminishing supply of GSH, there is an ac-
cumulation of excessive amounts of ROS and ultimately
cell death. Understanding the relationship between GSH
depletion and ROS production should lead to a better un-
derstanding of all forms of programmed cell death in
which ROS play a central role.
Oxidative glutamate toxicity has been observed in pri-
mary neuronal cell cultures (Murphy et al., 1989, 1990;
Oka et al., 1993), neuronal cell lines (Miyamoto et al.,
1989; Murphy et al., 1989), and tissue slices (Vornov and
Coyle, 1991) and has been studied recently in the immor-
talized mouse hippocampal cell line, HT22 (Davis and Ma-
her, 1994; Maher and Davis, 1996; Li et al., 1997
 
a
 
,
 
b
 
; Sagara
et al., 1998). In HT22 cells, glutamate induces a form of
programmed cell death with characteristics of both apop-
tosis and necrosis (Tan et al., 1998). HT22 cells exposed to
5 mM glutamate do not change morphologically until after
7 h of glutamate exposure. At this time, cells become
rounded and form apoptotic bodies before becoming
smaller shrunken cells. After 10 h, most cells are very
small and dead or close to death (Tan et al., 1998). The ex-
posure of HT22 cells, cortical neurons, and neuroblastoma
cells to glutamate results in the rapid depletion of GSH
followed by an increase in ROS (Murphy et al., 1989; Oka
et al., 1993; Li et al., 1997
 
a
 
; Sagara et al., 1998). The as-
sumption has been that the increase in ROS is a direct re-
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1. 
 
Abbreviations used in this paper
 
: BSO, 
 
l
 
-buthionine-[S,R]-sulfoximine;
DCF, dichlorofluorescin diacetate; FCCP, carbonyl cyanide 
 
p
 
-trifluo-
romethoxyphenyl-hydrazone; GSH, glutathione; ICE, interleukin 1
 
b
 
–con-
verting enzyme; Indo-1, indo-acetoxymethylester; 12-LOX, 12-lipoxygen-
ase; MAO, monoamine oxidase; 
 
p
 
-HPAA, 
 
p
 
-hydroxyphenylacetic acid;
ROS, reactive oxygen species.
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sult of this GSH depletion, but the functional relationship
between the two has not been defined. The experiments
outlined below show that GSH depletion alone cannot ac-
count for the increase in ROS. Instead, high levels of ROS
production require both interleukin 1
 
b
 
–converting en-
zyme (ICE) protease activity and early gene expression.
We also provide the first evidence that the majority of the
ROS in oxidative glutamate toxicity are generated from
the mitochondrial electron transport chain. Finally, extra-
cellular Ca
 
2
 
1
 
 influx is shown to regulate ROS production.
 
Materials and Methods
 
The following supplies were purchased from Sigma Chemical Co. (St.
Louis, MO): cycloheximide, actinomycin D, carbonyl cyanide 
 
p
 
-trifluo-
romethoxyphenyl-hydrazone (FCCP), 4,4,4-trifluoro-1-[2-thienyl]-1,3-
butanedione, 1-chloro-2,4-dinitrobenzene, antimycin A, rotenone, oligo-
mycin, GSH, glutathione reductase, triethanolamine, sulfosalicylic acid,
NADPH, 5,5
 
9
 
-dithiobis (2-nitrobenzoic acid), 
 
l
 
-buthionine-[S,R]-sulfox-
imine (BSO), horseradish peroxidase (Sigma Type VI), 
 
p
 
-hydroxypheny-
lacetic acid (
 
p
 
-HPAA), hydrogen peroxide (H
 
2
 
O
 
2
 
), and 
 
l
 
-glutamic acid.
2
 
9
 
,7
 
9
 
-dichlorofluorescein diacetate (DCF), indo-acetoxymethylester (Indo-
1), pluronic F-127, and propidium iodide were obtained from Molecular
Probes (Eugene, OR). Ac-YVAD-cmk, also known as ICE inhibitor II,
was from both Calbiochem (La Jolla, CA) and Bachem California (Tor-
rance, CA).
 
Cell Culture
 
HT22 cells were maintained in DME supplemented with 10% fetal bovine
serum. Cells were kept at no greater than 50% confluence.
 
Flow Cytometric Studies
 
Cells were plated at 2 
 
3 
 
10
 
5
 
 cells per dish on 60-mm tissue culture dishes
(Falcon, Lincoln Park, NJ) 12 h before glutamate exposure. Inhibitors
were added either at the same time as 5 mM 
 
l
 
-glutamic acid (glutamate)
or at 2-h intervals after glutamate addition to determine how late the drug
could be added and still prevent ROS production and/or protect the cells
from death.
 
ROS Measurement
 
Time course experiments were performed to compare ROS production in
HT22 cells after different lengths of glutamate exposure. ROS production
was detected using the dye DCF. DCF is a nonfluorescent cell-permeant
compound. Once inside the cell, it is cleaved by endogenous esterases and
can no longer pass out of the cell. The de-esterified product becomes the
fluorescent compound 2
 
9
 
,7
 
9
 
-dichlorofluorescein upon oxidation by ROS
(Bass et al., 1983; Cathcart et al., 1983; Hirabayashi et al., 1985; Miyamoto
et al., 1989; LeBel et al., 1992). 10 
 
m
 
M DCF was added to cells during dis-
sociation with pancreatin (GIBCO BRL, Gaithersburg, MD) diluted 1:5
in serum-free DME. The cells were then incubated at 37
 
8
 
C for 10 min and
washed once in Hepes buffer supplemented with 2% dialyzed fetal bovine
serum. Washed cells were resuspended in 750 
 
m
 
l Hepes buffer, filtered
through a 4-
 
m
 
m nylon mesh membrane (Small Parts Inc., Miami Lakes,
FL), and kept on ice until flow cytometric analysis. Propidium iodide dye
was used to gate for live cells and was added to each tube at a final con-
centration of 5 
 
m
 
g per ml. Data were collected with a FACScan
 
®
 
 fluores-
cence accelerated cell scanner using the data acquisition program
CELLQuest (Becton Dickinson, San Jose, CA). DCF data were collected
with the following excitation and emission wavelengths: 
 
l
 
exc
 
 
 
5 
 
475 nm,
 
l
 
em
 
 
 
5 
 
525 nm. 10,000 live cells, as determined by the lack of propidium io-
dide fluorescence, were analyzed per sample. To the best of our knowl-
edge, ROS production leads directly to DCF oxidation. The dissociation
of cells before measuring DCF fluorescence accurately reflects the
amount of ROS present in the plated cells at the time just before dissocia-
tion. Visual inspection using fluorescence microscopy confirms the in-
crease in fluorescence with lengthened exposures to glutamate in the
plated cells. This late high intensity fluorescence was blocked by a caspase
inhibitor, protein synthesis inhibitors, FCCP, ruthenium red, and cobalt
(Figs. 2, 
 
A
 
–
 
C
 
, 3 
 
A
 
, 7, and 8). In addition, DCF fluorescence was the same
in attached cells loaded with DCF before dissociation and in cells loaded
 
with DCF while dissociation took place. Similar results were also seen us-
ing the dye dihydrorhodamine 123.
Percent cell survival at each time point was determined by trypan blue
staining after each sample was analyzed by flow cytometry. Cells were di-
luted 1:2 with 0.1% trypan blue (ICN Biomedicals, Costa Mesa, CA) in
PBS. Live cells were then counted under a light microscope. Live cells
were not permeable to trypan blue and remained clear and phase bright.
Percent survival was calculated versus the negative control.
DCF data were plotted as histograms using the data analysis program
CELLQuest (Becton Dickinson). The median fluorescence of each peak
was obtained and multiplied by the number of events in that peak. Sample
values were divided by the control value to yield the ratiometric increase
in DCF fluorescence per time point.
 
Calcium Measurement
 
Cytosolic Ca
 
2
 
1
 
 was measured using the dye Indo-1 acetoxymethylester
(Indo-1) and flow cytometry. Once inside the cell, the Indo-1 acetoxy-
methylester is cleaved by endogenous esterases, and Indo-1 is trapped in-
side the cell. The dye then binds Ca
 
2
 
1
 
, and upon excitation by UV light, it
emits fluorescent light at two wavelengths: 410 nm (FL32) and 485 nm
(FL4). The Ca
 
2
 
1
 
 concentration present in the cell is proportional to the ra-
tio of FL32/FL4, which reflects the fluorescence of Indo-1 bound to Ca
 
2
 
1
 
versus the fluorescence of Indo-1 that is not bound to Ca
 
2
 
1
 
. The ratio of
bound to unbound dye accounts for any changes that take place in the
cell’s volume upon glutamate exposure. HT22 cells were loaded with 1
 
m
 
M Indo-1 in the presence of 0.005% Pluronic F-127 for 30 min at 37
 
8
 
C.
Cells were then dissociated from the dishes in the presence of 10 
 
m
 
M
DCF, washed, and analyzed as described above. Ca
 
2
 
1
 
 data were plotted as
dot plots, and the fluorescence above a certain wavelength was designated
as high. The number of cells with high fluorescence was calculated for
each sample, and the ratiometric increase of cells with high Ca
 
2
 
1
 
 was de-
termined with respect to the control value. The effects of the inhibitors
CoCl
 
2
 
, ruthenium red, and FCCP on cytosolic Ca
 
2
 
1
 
, ROS levels, and cell
death were observed by adding glutamate to HT22 cells and then adding
the inhibitors either at the same time as or at 2-h intervals after the
glutamate addition.
 
Glutathione Chemical Assay
 
Total intracellular reduced (GSH) and oxidized (GSSG) glutathione was
measured using a method by Tietze (1969), as modified by Griffith (1980).
Cells were plated on 100-mm tissue culture dishes at 5 
 
3 
 
10
 
5
 
 cells per dish
12 h before 5 mM glutamate or 50 
 
m
 
M BSO treatment. Cells were pro-
cessed as described previously by Sagara et al. (1998). Pure GSH was used
to obtain a standard curve.
 
In Vitro Determination of Mitochondrial H
 
2
 
O
 
2
 
 Release
 
The release of H
 
2
 
O
 
2
 
 by isolated mitochondria from HT22 cells was done
by the method described by Liu et al. (1993). Briefly, 
 
p
 
-HPAA (Guilbault
et al., 1968) was used as a substrate that is converted by HRP to a fluores-
cent compound in the presence of H
 
2
 
O
 
2
 
. Mitochondria from HT22 cells
were isolated according to the method of Moreadith and Fiskum (1984),
with the exception that the second homogenization step was eliminated.
Cells were grown to confluence in 12 150-mm tissue culture dishes to ob-
tain a large quantity of mitochondria. To measure H
 
2
 
O
 
2
 
 release, 0.1 mg/ml
mitochondria were incubated in KCl buffer (125 mM KCl, 2 mM K
 
2
 
HPO
 
4
 
,
1 mM MgCl
 
2
 
, and 20 mM Hepes, adjusted to pH 7.4 with KOH) and the
H
 
2
 
O
 
2
 
 detection system (0.2 mM 
 
p
 
-HPAA and 0.5 
 
m
 
M HRP) at 37
 
8
 
C. 6 mM
succinate or 6 mM malate plus 6 mM glutamate were added as FAD-linked
or NADH-linked substrates for the mitochondrial electron transport
chain. To quantitate the amount of H
 
2
 
O
 
2
 
 released by the mitochondria, a
known amount of H
 
2
 
O
 
2
 
 was used to compare the amount of fluorescence
obtained in the experimental samples. All measurements were made using
a Perkin-Elmer LS-50B fluorescence spectrometer (Norwalk, CT).
 
Exposure of Cells to Cystine-free Media
 
Cells were plated as described above. 12 h after plating, the medium was
replaced with cystine-free DME supplemented with 10% dialyzed fetal
bovine serum. After 4 and 8 h exposure to cystine-free media, ROS levels
were determined with DCF as described above. The same experiment was 
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done using 5 mM glutamate to compare the amount of ROS production
caused by both conditions.
 
Statistics
 
Statistics were done using a Math-Stat program. Unless otherwise indi-
cated, the results are the mean plus or minus the standard error of the
mean of four independent determinations. For FACS
 
®
 
 analysis, 10,000
cells were quantitated.
 
Results
 
GSH Depletion Causes Only a Partial Increase in ROS
 
Although oxidative glutamate toxicity is associated with
the depletion of GSH (Murphy et al., 1989), the causal re-
lationship between GSH depletion and ROS production
has not been formally explored. Exposure of HT22 cells to
glutamate leads to the increased production of ROS. This
increase is concurrent with the depletion of GSH, which is
caused by the inability of the cells to take up the cystine
necessary for GSH production (Fig. 1 
 
A
 
). ROS production
proceeds in two phases: an initial slow increase for the first
6 h, followed by a much higher rate (Fig. 1 
 
B
 
). By 10 h, the
intracellular ROS levels are over 200 times greater than
the control levels. The latter high rate of increase in ROS
only begins after the cellular GSH levels drop below
 
z
 
20%.
There are three alternatives that could explain the ap-
parent temporal coupling between GSH depletion and
ROS production: (
 
a
 
) The increase in ROS is exclusively
due to GSH depletion. (
 
b
 
) Glutamate may cause an eleva-
tion in ROS levels independently of GSH depletion. (
 
c
 
)
One phase of ROS production is due to GSH depletion,
and the other is not directly coupled to this event. To dis-
tinguish between these possibilities, GSH levels were de-
pleted with BSO, an irreversible inhibitor of 
 
g
 
-glutamyl-
cysteine synthetase. ROS levels were examined during
BSO-induced GSH depletion and compared with the lev-
els after glutamate-induced GSH depletion (Fig. 1 
 
A
 
).
While 50 
 
m
 
M BSO is capable of depleting cellular GSH to
the same levels as glutamate after 8–10 h of exposure, the
ROS level in BSO-treated cells at 10 h is only 20% of that
in glutamate-treated cells. In contrast, the initial rate of
ROS production is about the same with BSO and glutamate.
It can be concluded that while the depletion of GSH is
necessary for the initial increase in ROS production, its
decrease is not sufficient to generate the late exponential
increase in ROS, which occurs after 6 h of glutamate treat-
ment.
 
Gene Expression and ICE Protease Activity Are 
Necessary for ROS Production
 
Oxidative glutamate toxicity in HT22 cells is a form of
programmed cell death (Tan et al., 1998). Most forms of
programmed cell death, including that of HT22 cells, are
blocked by macromolecular synthesis inhibitors as well as
by caspase inhibitors. It was therefore important to deter-
mine whether ROS production is a signal for changes in
macromolecular synthesis and protease activation or if it is
dependent on gene expression and caspase activity. To an-
swer this question, specific inhibitors were used to exam-
ine the roles of RNA and protein synthesis and ICE pro-
tease activity in ROS production after glutamate exposure.
Glutamate was added to cells, and at 2-h intervals the in-
hibitors were applied. At 10 h, GSH and ROS levels were
determined, and cell viability was scored. Surprisingly,
these inhibitors all block the late second phase of ROS
production, but only when added early in the cell death
cascade (Fig. 2). However, even when added immediately
before glutamate, they do not block the first phase of ROS
production (data not presented).
Actinomycin D prevents the increase in ROS and pro-
tects the cells from glutamate toxicity only when it is
added within 2 h of the glutamate exposure (Fig. 2 
 
A
 
).
Similarly, cycloheximide is able to protect HT22 cells and
keeps ROS levels low during a 10-h glutamate exposure
when the inhibitor is added up to 6 h after glutamate (Fig.
2 
 
B
 
). If the inhibitor is added to the cells later than 6 h,
ROS levels increase, and cell survival is less than 15% of
that in the control. Cell survival is also increased and ROS
production is decreased by the addition of the ICE pro-
tease inhibitor, Ac-YVAD-cmk (Fig. 2 
 
C
 
). Ac-YVAD-cmk
must be added within the first 4 h of glutamate exposure to
keep ROS levels low and protect the cells. Therefore, the
requirement for ICE proteases is very early in the death
cascade. None of the above inhibitors prevents the deple-
tion of GSH (data not shown). Thus, the rapid rise of ROS
Figure 1. GSH depletion and ROS produc-
tion after exposure to glutamate or BSO. (A)
Glutamate (5 mM) or BSO (50 mM) were
added to cells, and GSH and ROS were mea-
sured as a function of time. The amount of
GSH was calculated as nmoles GSH per mg
protein and is presented as a percentage of
the control value. ROS are presented as the
ratiometric increase in median DCF fluores-
cence versus the control sample. Both GSH
and ROS were quantified at 2-h intervals up
to 10 h after the addition of glutamate. GSH
data are the average of five trials. GSH deple-
tion by BSO is an average of four trials. ROS
data are averages of eight trials. (black
squares) GSH, glutamate; (black circles)
ROS, glutamate; (white squares) GSH, BSO; (white circles) ROS, BSO. (B) The glutamate data from the above and similar experiments
were plotted in terms of GSH concentration (% maximum) vs. log ROS (% maximum). 
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production is dependent on both protein synthesis and
protease activation.
 
The Mitochondrial Electron Transport Chain Is the 
Major Source of ROS
 
The above data suggest that the large increase in ROS
production is not simply a consequence of GSH depletion.
There are many possible sources of ROS. They include mi-
tochondria and a wide array of enzymes such as the
monoamine oxidases, tyrosine hydroxylase, 
 
l
 
-amino oxi-
dase, the lipoxygenases, cyclo-oxygenase, and xanthine ox-
idase (Coyle and Puttfarcken, 1993). To determine if the
source of ROS is the mitochondrial electron transport
chain, transport chain inhibitors were tested for their ef-
fects on ROS production and cell survival. The mitochon-
drial uncoupler, FCCP, dissipates the mitochondrial
membrane potential by transporting protons across the
membrane and down the proton gradient (Voet and Voet,
1990). Fig. 3 
 
A
 
 shows that 5 
 
m
 
M FCCP protects the cells
from glutamate toxicity and prevents the massive increase
in ROS production, allowing only a 10-fold increase,
which is similar to that observed before the exponential
rise at 6 h (Fig. 1). The complex III inhibitor, antimycin A,
also protects cells and keeps the ROS levels low (data not
shown). In contrast, both rotenone, an inhibitor of com-
plex I, and oligomycin, an inhibitor of the ATP synthase,
cause an increase in ROS in the absence of glutamate, and
glutamate addition increases ROS production over that
seen with the drugs alone (data not shown). These inhibi-
tor data were confirmed in vitro using mitochondria iso-
lated from HT22 cells and a fluorometric method of H
 
2
 
O
 
2
 
detection (Liu et al., 1993). FCCP prevents 97% of the
H
 
2
 
O
 
2
 
 production in isolated mitochondria through the
succinate pathway (Fig. 3 B). Antimycin A also lowers
the in vitro production of H2O2 through this pathway
(data not shown). Mitochondria isolated from HT22 cells
do not produce detectable H2O2 in the presence of
glutamate or malate (data not shown).
The monoamine oxidase-A (MAO-A) inhibitor clor-
gyline protects HT22 cells from glutamate-induced toxic-
ity and prevents the major glutamate-induced increase in
ROS (Maher and Davis, 1996). In vitro data using mito-
chondria isolated from HT22 cells demonstrate that both
pargyline, an inhibitor of MAO-B, and clorgyline are able
to prevent H2O2 production when the MAO substrates
tryptamine or tyramine are added to mitochondria (data
not shown). However, only clorgyline is able to prevent
H2O2 production when the mitochondrial electron trans-
port chain substrate, succinate, is supplied to mitochondria
(Fig. 3 C). In vivo data indicate that H2O2 production is re-
duced by clorgyline in a similar fashion as is seen with
FCCP (data not shown).
Because glutamate is a substrate for the mitochondrial
electron transport chain, it is possible that the increase in
ROS levels is caused simply by the presence of excess
glutamate in the cells. To rule out this possibility, cells
were placed in cystine-free media, and ROS production
was monitored. Depleting the cells of cysteine produces
the same result as was achieved with glutamate (Fig. 4).
The cells die within 24 h, and ROS levels at 4 and 8 h are
similar to those with 5 mM glutamate.
Cytosolic Ca21
Since an increase in cytosolic Ca21 is a common feature of
many forms of cell death (McConkey and Orrenius, 1997),
including oxidative glutamate toxicity (Murphy et al.,
1989; Davis and Maher, 1994), the relationship between
calcium and the two phases of ROS production was ex-
plored. To determine the temporal relationship between
Ca21 and ROS levels, both were measured in the same cell
at 2-h intervals after the addition of glutamate. Fig. 5
shows that there is very little increase in cytoplasmic Ca21
Figure 2. Inhibitors of macromolecular synthesis and ICE proteases prevent ROS production. Inhibitors were added to HT22 cells at 2-h
intervals during a 10-h exposure to 5 mM glutamate, and DCF fluorescence and cell survival were measured. ROS production is pre-
sented as the ratiometric increase in median DCF fluorescence versus the control value (black circles). Cell survival was measured by
trypan blue exclusion and is presented as the percent of the control value (black squares). Each set of data represents the mean of two
trials that were repeated four times, plus or minus the standard error. (A) Effect of actinomycin D on ROS production and cell survival.
0.1 mg/ml actinomycin D was added to HT22 cells at 2-h intervals during a 10-h exposure to 5 mM glutamate. (B) Effect of cyclohexi-
mide on ROS production and cell survival. 300 nM cycloheximide was added to HT22 cells during a 10-h exposure to 5 mM glutamate. (C)
Effect of Ac-YVAD-cmk on ROS production and cell survival. 50 mM Ac-YVAD-cmk was added to HT22 cells as in parts A and B.Tan et al. Reactive Oxygen Species and Cell Death 1427
until the cells enter the second (late) phase of ROS pro-
duction, and then Ca21 is high only in cells that have accu-
mulated a high ROS load. These data suggest that the late
phase mitochondrial ROS may be necessary for Ca21 ac-
cumulation. To test this possibility, ROS production from
the electron transport chain was eliminated by FCCP, and
intracellular Ca21 was monitored. Fig. 6 shows that Ca21
levels increase to less than 15% of that in cells exposed to
glutamate alone. Although FCCP itself is slightly toxic to
cells after 8–10 h, it blocks glutamate-induced cell death
(Fig. 3 A and Fig. 6) as well as the normal increase in Ca21.
Therefore, late-phase ROS production has a major effect
on intracellular Ca21 concentration.
To further examine the relationship between Ca21 and
ROS, we asked if there were a reciprocal relationship be-
tween the two. Does the inhibition of Ca21 uptake block
ROS production? CoCl2 is a Ca21 channel blocker that in-
hibits the influx of extracellular Ca21 through most plasma
membrane Ca21 channels (McFarlane et al., 1993). To de-
termine when in the toxicity cascade extracellular Ca21 en-
ters the cell and the extent to which it modifies ROS pro-
duction, CoCl2 was added to cells at 2-h intervals after the
addition of glutamate. ROS and Ca21 levels were moni-
tored, and cell viability was determined 10 h after the addi-
tion of glutamate. When CoCl2 is added up to 6 h after the
glutamate addition, HT22 cells are protected from cell
death (Fig. 7). Previous work has also shown that cobalt
completely protects cells from oxidative glutamate toxicity
(Murphy et al., 1989; Davis and Maher, 1994; Li et al.,
1997b). When cells are protected by CoCl2, the late phase
of ROS increase is reduced to about 30% of the maximum,
and cytosolic Ca21 levels only increase to about 10% of
the maximum level (Fig. 7). Since the inhibition of mito-
chondrial ROS production reduces intracellular Ca21 to
15% of its maximum in the presence of glutamate alone
(Fig. 6), and ROS levels only reach 30% of their maximum
in the presence of cobalt (Fig. 7), it follows that there is a
mutual requirement for Ca21 and ROS for each to reach
their maximal level.
The above data show that the major source of intracellu-
lar free Ca21 is from outside the cell via cobalt-sensitive
channels. How can this Ca21 influence mitochondrial ROS
Figure 3. Effect of uncoupling mitochondria on ROS production. (A) 5 mM of the protonophore FCCP was added to the cells at 2-h in-
tervals after glutamate exposure to see how late the inhibitor could be added and still protect cells. ROS levels are expressed as the rati-
ometric increase in median DCF fluorescence versus the control value (black circles). Cell survival is the percent of the control (black
squares). (B) In vitro production of H2O2 by mitochondria from HT22 cells was determined by fluorescence spectrometry using the flu-
orescent substrate, p-HPAA. Basal H2O2 production was initiated by providing mitochondria with 6 mM succinate. Once H2O2 pro-
duction was established, 0.2 mM FCCP was added, resulting in inhibition of H2O2 production. 0.1 mM H2O2 was added to indicate the
increase in relative fluorescence with a known concentration of H2O2. (C) In vitro production of H2O2 by mitochondria from HT22 cells
was established as in B. Basal H2O2 production was initiated by providing the mitochondria with 6 mM succinate. 100 mM pargyline had
no effect on H2O2 production, while 100 mM clorgyline decreased H2O2 production to less than 10% of the basal level. 0.1 mM H2O2 was
added to indicate the increase in relative fluorescence with a known concentration of H2O2.
Figure 4. ROS production in
cystine-free medium. Cells
were exposed to either cys-
tine-free medium supple-
mented with 10% dialyzed
fetal bovine serum or 5 mM
glutamate. The ratiometric
increase in median DCF flu-
orescence versus the control
value was determined after 4
and 8 h exposure for each
sample.The Journal of Cell Biology, Volume 141, 1998 1428
production? Ruthenium red is a potent inhibitor of both
the mitochondrial Ca21 uptake uniporter and the ryano-
dine receptor–mediated Ca21 channel on the ER (Gunter
and Pfeiffer, 1990; McPherson and Campbell, 1993; Kohda
et al., 1995; Park et al., 1996). If mitochondrial Ca21 up-
take is required for ROS production, then ruthenium red
should block the late phase of ROS. Fig. 8 shows that ru-
thenium red protects the cells when added up to 6 h after
glutamate. In addition, ruthenium red keeps cytosolic
Ca21 levels at baseline levels and allows only the early in-
crease in ROS production (Fig. 8). When ruthenium red is
added to the cells after they have been exposed to
glutamate for more than 6 h, cell survival is very low, and
ROS and Ca21 increase to much higher levels. Since mito-
chondria are responsible for late-phase ROS production
and since the mitochondrial Ca21 uptake inhibitor ruthe-
Figure 5. ROS production
and intracellular Ca21
changes. ROS were moni-
tored (DCF fluorescence,
horizontal axis) at the same
time as intracellular Ca21
levels (Indo-1, vertical axis)
during a 10-h exposure to 5
mM glutamate. Data from
10,000 live cells were col-
lected for each graph.
Figure 6.C a 2 1  changes and the mitochondrial electron transport
chain. Ca21 levels were monitored at 2-h intervals in cells treated
with 5 mM FCCP 1 glutamate (black squares) or with glutamate
alone (black circles) during a 10-h time course. Ca21 increase is
expressed as the ratiometric increase in the number of cells with
high fluorescence (Fig. 5, top) with respect to the control. Cell
survival is expressed as a percent of the control (dotted lines) and
is normalized to the number of cells surviving after the exposure
to 5 mM FCCP in the absence of glutamate. Survival in FCCP
alone at 10 h was 40%.
Figure 7. Cytosolic Ca21 changes that are due to the influx of
Ca21. Glutamate was added to all samples for 10 h, while 20 mM
CoCl2 was added at 2-h intervals after glutamate to determine
how late into the glutamate exposure CoCl2 could be added and
still protect cells from death. Cell viability was determined after
24 h. Ca21 changes were detected as an increase in Indo-1 fluores-
cence over a wavelength designated as high (Fig. 5) and pre-
sented as a ratiometric increase with respect to the control (black
circles). ROS production is measured using DCF as in previous
figures (black squares). Cell survival is shown as a percentage of
the control (bars). The * symbol indicates that P , 0.05 between
the 6- and the 8-h time points.Tan et al. Reactive Oxygen Species and Cell Death 1429
nium red inhibits this process, it follows that Ca21 uptake
into mitochondria is a necessary step for the high rate of
ROS formation.
Discussion
Previous work has defined oxidative glutamate toxicity in
terms of the depletion of intracellular cysteine and the
subsequent decrease in GSH (Murphy et al., 1989). In the
hippocampal cell line HT22, these events lead to a form of
programmed cell death that is similar to, but distinct from,
classical apoptosis (Tan et al., 1998). The data presented
here outline the temporal and functional relationships be-
tween glutamate, GSH, Ca21, ROS, and cell death. ROS
production is divided into two phases: an initial 5–10-fold
increase followed by a massive 200–400-fold increase. The
source of ROS in the latter phase is identified as the mito-
chondrial electron transport chain. The large second phase
increase in ROS production is not due solely to the deple-
tion of GSH. ICE protease activity, macromolecular syn-
thesis, and Ca21 fluxes all contribute to the mitochondria-
generated large increase in ROS but are not required for
the initial increase.
There Are Two Phases of ROS Production
When glutamate is added to cells and the accumulation of
ROS followed as a function of time, there is a gradual in-
crease in ROS for the first 6 h, followed by an explosive in-
crease in the rate of production after 6 h (Fig. 1). The slow
accumulation of ROS occurs until GSH levels fall below
20%. After this juncture, ROS begin to accumulate at a
much greater rate (Fig. 1 B). To determine the contribu-
tion of GSH to the increase in ROS, cells were depleted of
GSH by the g-glutamylcysteine synthetase inhibitor, BSO.
BSO completely depletes cellular GSH but causes only a
20–25% increase in ROS relative to glutamate (Fig. 2).
Therefore, the loss of GSH alone cannot account for the
greater than 200-fold increase in ROS that is seen with
glutamate. Mitochondria contain z15–20% of the total in-
tracellular GSH (Jocelyn, 1975; Ravindranath and Reed,
1990), and it has been suggested that ROS increase uncon-
trollably when mitochondrial GSH stores are depleted
(Reed and Savage, 1995). The data with BSO show that
the severe depletion of intracellular GSH does not neces-
sarily lead to maximal ROS production. The differences in
ROS production between these two methods of GSH de-
pletion indicate that there is a specific event that takes
place in the presence of glutamate and/or cysteine deple-
tion, which leads to extreme ROS production when GSH
levels drop below 20%. In the case of BSO depletion, in-
tracellular cysteine remains high and may prevent the sec-
ond burst of ROS production by acting as an antioxidant.
Only after the loss of the antioxidants cysteine and GSH is
there the second large rise in ROS. Therefore, the major-
ity of the ROS production in oxidative glutamate toxicity
is not simply a by-product of GSH depletion.
The Majority of the ROS Is Produced by the 
Mitochondrial Electron Transport Chain
Evidence that the late burst of ROS formation comes from
the mitochondrial electron transport chain is most clearly
seen when FCCP is used to uncouple oxidative phosphory-
lation, resulting in the loss of ROS formation (Fig. 3, A
and B). FCCP dissipates the proton gradient that is gener-
ated for the production of ATP. During uncoupling, the
electron transport chain works more efficiently to reestab-
lish the proton gradient, while ATP synthesis becomes de-
pendent upon glycolysis. The increase in efficiency leads
to less leakage of electrons and therefore much lower lev-
els of ROS are generated (Boveris et al., 1972; Boveris and
Chance, 1973; Cino and Del Maestro, 1989).
Other inhibitors of the electron transport chain, rote-
none and antimycin A, as well as one inhibitor of oxidative
phosphorylation, oligomycin, were also used to identify
the source of ROS production. Antimycin A decreases the
rate of ROS production in cells and isolated mitochondria.
Because this drug itself causes ROS production at a lower
rate than glutamate-induced ROS production, it lowers
the ROS produced by glutamate and protects the cells.
The fact that it can prevent the effects of glutamate con-
firms that the majority of the late-phase ROS in oxidative
glutamate toxicity come from the electron transport chain.
Rotenone and oligomycin are unable to protect the cells
from glutamate because they cause extreme increases in
ROS production by themselves.
Glutamate acts as a substrate for complex I of the mito-
chondrial electron transport chain through the glutamate–
malate shuttle. It is therefore possible that excess glutamate
could increase electron flow into the transport chain, lead-
ing to elevated ROS production. However, the same in-
crease in ROS production is seen with cystine-free medium
(Fig. 4), indicating that increased ROS production is not
Figure 8. Intracellular Ca21 cycling during glutamate exposure.
Glutamate was added to all samples for 10 h, and 150 mM ruthe-
nium red was added to the cells at 2-h intervals after the addition
of glutamate. Ca21 changes were detected as an increase in Indo-1
fluorescence over a wavelength designated as high, and data are
presented as a ratiometric increase with respect to the control
(black circles). ROS were detected using DCF and are expressed
as the ratio of the median DCF fluorescence with respect to the
control (black squares). Cell survival at 10 h is expressed as a per-
centage of the control (bars).The Journal of Cell Biology, Volume 141, 1998 1430
simply due to more substrate. In addition, mitochondria
isolated from HT22 cells do not produce detectable ROS
in the presence of glutamate (data not presented). The fact
that the ROS production during cystine deprivation is so
similar to glutamate-induced ROS production supports
the data showing that glutamate acts by blocking the cys-
teine/glutamate antiporter in HT22 cells.
The monoamine oxidase A inhibitor clorgyline inhibits
oxidative glutamate toxicity in HT22 cells, but only at con-
centrations 100-fold higher than those required to inhibit
the MAO activity (Maher and Davis, 1996). Since the late
robust ROS production originates from mitochondria, it
was asked if clorgyline is also able to block this event. Fig.
3 C shows that clorgyline blocks mitochondrial H2O2 pro-
duction at high concentrations, suggesting that this is how
it prevents cell death. More work must be done to under-
stand the mechanism by which clorgyline protects HT22
cells. However, according to Fig. 3 C it is possible that clor-
gyline binds to a flavin-binding protein of the mitochon-
drial electron transport chain, thus inhibiting ROS produc-
tion by blocking electron transport.
Gene Expression and ICE Protease Activity Are 
Necessary for ROS Production
Fig. 2 demonstrates that proteases and newly synthesized
proteins are used to signal late ROS production when cells
are exposed to glutamate. The effectiveness of the three
inhibitors, actinomycin D, cycloheximide, and Ac-YVAD-
cmk, in blocking cell death and late ROS production em-
phasizes the role of macromolecular synthesis and caspases
in regulating ROS. A combination of several signals may
lead to the 200-fold increase in ROS production seen in
Fig. 1. For example, GSH depletion, the initial 5–10-fold
increase in ROS, and newly synthesized proteins may all
act synergistically to stimulate mitochondrial ROS forma-
tion. Previous work suggests that ROS can act as signals in
apoptotic cell death (Chaudhri et al., 1986, 1988; Naka-
mura et al., 1993; Staal et al., 1994; Russo et al., 1995; Slater
et al., 1995; Kazzaz et al., 1996; Abe et al., 1997; Esposito
et al., 1997; Goldstone and Hunt, 1997). Therefore, the ini-
tial small increase in ROS may be the signal that leads to
the changes in gene expression required to initiate the
death program. The depletion of cysteine and GSH, which
are antioxidants, may be directly responsible for the initial
ROS accumulation.
The time course experiments of Fig. 2 indicate that
changes in gene expression are required within the first 6 h
of the cell death pathway. Both actinomycin D and cyclo-
heximide prevent almost all ROS production when added
at the same time as the glutamate, but they do not prevent
GSH depletion. Ac-YVAD-cmk allows an z10-fold in-
crease in ROS when it is added with glutamate, has no ef-
fect on GSH depletion, and yet still totally protects the
cells when added at the same time as glutamate. One pos-
sible role of the ICE proteases may be to prevent an initial
protective role of ROS. Evidence that a small increase in
ROS can signal a protective mechanism is shown by the
observation that if glutamate treatment is less than 6 h, the
cells survive and continue dividing, in spite of the activa-
tion of genes that contribute to the increase in ROS pro-
duction. Because ICE proteases seem to be activated
within the first 2 h of exposure to glutamate, it is likely that
they are already present in the cell but are only activated
with the addition of glutamate. This conclusion is consistent
with the observation that glutamate-induced macromolec-
ular synthesis seems to occur both during and after the
ICE protease activation. Although the signals that lead to
gene expression and ICE protease activation are unknown,
they are necessary to generate the large increase in ROS.
In addition to macromolecular synthesis changes and
protease activation, 12-lipoxygenase (12-LOX) activity is
required for maximal late-phase mitochondrial ROS pro-
duction and cell death (Li et al., 1997a). In the presence of
glutamate, low intracellular GSH activates 12-LOX, gen-
erating an unidentified product that is required for maxi-
mum ROS levels but has no effect on the initial small in-
crease in ROS. The 12-LOX product may interact with
mitochondria directly to increase ROS production, but it
also activates guanylate cyclase and the production of
cGMP. cGMP, in turn, activates a cobalt-sensitive Ca21
channel, allowing for the large increase in intracellular
Ca21 near the point of cell lysis (Li et al., 1997b). As out-
lined in the following section, there is a reciprocal interac-
tion between Ca21 elevation and ROS formation, so it
cannot be stated with certainty where in the death cascade
12-LOX products are influencing ROS formation. It is
clear, however, that a series of parallel biochemical events
are required to achieve the final burst of mitochondrial
ROS that precedes cell lysis. Each appears to be neces-
sary, but none sufficient to carry out the death program.
The Role of Ca21 in ROS Production and Cell Death
A major event during programmed cell death is the in-
crease in cytosolic Ca21 (for review see McConkey and
Orrenius, 1997). Although the interaction of Ca21 with the
ROS-generating systems is not well understood, an outline
of the temporal and functional interactions between Ca21
metabolism and ROS formation in HT22 cells after
glutamate exposure can be made. Fig. 5 shows that the
late-phase increase in mitochondrial-derived ROS pre-
cedes cytosolic Ca21 elevation. When late-phase ROS pro-
duction is blocked by FCCP, there is no increase in intra-
cellular Ca21 (Fig. 6). Conversely, if Ca21 influx is blocked
by cobalt, there is little increase in ROS (Fig. 7). There-
fore, the influx of Ca21 and mitochondrial ROS produc-
tion appear to be tightly coupled. Since ruthenium red in-
hibits both the uptake of Ca21 into mitochondria and
glutamate toxicity (Fig. 8), it is likely that Ca21 uptake into
mitochondria is necessary for maximal ROS production.
Because ruthenium red also regulates Ca21 metabolism
from the endoplasmic reticulum, it is possible that the
early, low-level increases in Ca21 are derived from intra-
cellular stores, either in the ER or mitochondria, and that
these stores may be required for the signaling leading to
the later mitochondrial burst of ROS. More work is re-
quired, however, to firmly establish this relationship.
It has been shown that Ca21 is a common signal in many
different cell death pathways and that there is an intricate
relationship between mitochondrial function, ROS pro-
duction, Ca21, and cell death (Randall and Thayer, 1992;
Reynolds and Hastings, 1995; Richter et al., 1995; Budd
and Nicholls, 1996a,b; Isaev et al., 1996; Macho et al.,Tan et al. Reactive Oxygen Species and Cell Death 1431
1997). Depletion of the ER Ca21 pool can lead to apopto-
sis (He et al., 1997), while loss of mitochondrial function
causes an increase in cytosolic Ca21 (Luo et al., 1997). Like
HT22 cells undergoing oxidative glutamate toxicity, recep-
tor-mediated glutamate toxicity is blocked by CoCl2 and
ruthenium red (Dessi et al., 1995; Thayer and Wang, 1995;
Isaev et al., 1996; Korkotian and Segal, 1996). It is there-
fore likely that there is a common pathway of pro-
grammed cell death that uses ROS and Ca21 in spite of dif-
ferences in the initial cytotoxic insults (Richter et al.,
1995).
In summary, these data show that there are two phases
of ROS formation after exposure to glutamate: an early
5–10-fold increase coupled to GSH depletion and a later
200–400-fold increase derived from mitochondria. Early
gene activation and caspase activity are required for both
maximal ROS production and subsequent cell death. This
knowledge provides a conceptional framework on which
to delineate the molecular mechanisms that lead to oxida-
tive glutamate toxicity and other forms of programmed
cell death in which ROS are involved.
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